Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Keratin 33A is a key protein in goat winter coats, especially in high-producing breeds.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Using neurohormones to control keratin can lead to new skin disease treatments.

High BMI worsens hair growth in women with PCOS.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

The document concludes that more research is needed to fully understand the causes of PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Ficus carica extract improved fertility in rats and may help with certain health conditions.